Citadel Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-10,792
| Closed | -$40K | – | 4707 |
|
|
2017
Q4 | $40K | Sell |
10,792
-5,334
| -33% | -$19.8K | ﹤0.01% | 3670 |
|
|
2017
Q3 | $66K | Sell |
16,126
-3,361
| -17% | -$13.8K | ﹤0.01% | 3386 |
|
|
2017
Q2 | $72K | Sell |
19,487
-14,628
| -43% | -$54K | ﹤0.01% | 3343 |
|
|
2017
Q1 | $142K | Buy |
+34,115
| New | +$142K | ﹤0.01% | 3274 |
|
|
2016
Q4 | – | Sell |
-2,308
| Closed | -$23K | – | 4406 |
|
|
2016
Q3 | $23K | Sell |
2,308
-1,627
| -41% | -$16.2K | ﹤0.01% | 3396 |
|
|
2016
Q2 | $22K | Buy |
3,935
+1,639
| +71% | +$9.16K | ﹤0.01% | 3171 |
|
|
2016
Q1 | $17K | Sell |
2,296
-35,073
| -94% | -$260K | ﹤0.01% | 3193 |
|
|
2015
Q4 | $498K | Buy |
37,369
+34,310
| +1,122% | +$457K | ﹤0.01% | 2396 |
|
|
2015
Q3 | $50K | Sell |
3,059
-20,242
| -87% | -$331K | ﹤0.01% | 3545 |
|
|
2015
Q2 | $523K | Buy |
+23,301
| New | +$523K | ﹤0.01% | 2525 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4204 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4116 |
|
|
2014
Q3 | – | Sell |
-2,372
| Closed | -$46K | – | 3898 |
|
|
2014
Q2 | $46K | Sell |
2,372
-1,122
| -32% | -$21.8K | ﹤0.01% | 3135 |
|
|
2014
Q1 | $62K | Sell |
3,494
-172
| -5% | -$3.05K | ﹤0.01% | 3216 |
|
|
2013
Q4 | $39K | Sell |
3,666
-19,603
| -84% | -$209K | ﹤0.01% | 2791 |
|
|
2013
Q3 | $288K | Sell |
23,269
-27,692
| -54% | -$343K | ﹤0.01% | 2144 |
|
|
2013
Q2 | $477K | Buy |
+50,961
| New | +$477K | ﹤0.01% | 1950 |
|